Biotricity Inc.
BTCYOTCCIK 1630113HealthcareFiscal year ends Mar 31
Reports and events: 187 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2823:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-044407 |
| 2026-08-1920:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-039209 |
| 2026-07-1421:25 ET | 10-K | Annual reportPeriod 2026-03-31 | 0001493152-26-033207 |
| 2026-05-0121:28 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-020939 |
| 2026-02-1822:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-007369 |
| 2026-02-1121:29 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001493152-26-006211 |
| 2025-12-1922:29 ET | S-1 | Registration statement | 0001493152-25-028614 |
| 2025-11-1821:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-024061 |
| 2025-11-1420:38 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-023361 |
| 2025-08-1411:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-023709 |
| 2025-07-1800:04 ET | 10-K/A | Annual report, amendedPeriod 2025-03-31 | 0001641172-25-020105 |
| 2025-07-1521:27 ET | 10-K | Annual reportPeriod 2025-03-31 | 0001641172-25-019755 |
| 2025-02-2422:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-007938 |
| 2025-02-2017:08 ET | 10-Q/A | Quarterly report, amendedPeriod 2024-12-31 | 0001493152-25-007664 |
| 2025-02-1922:30 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001493152-25-007608 |
| 2024-11-2002:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-046908 |
| 2024-11-1422:02 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-046028 |
| 2024-08-1921:24 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-033159 |
| 2024-08-1621:01 ET | 8-K | 5.07 Shareholder vote results | 0001493152-24-032861 |
| 2024-08-0721:30 ET | 8-K | 3.01 Delisting notice | 0001493152-24-030615 |
| 2024-08-0512:48 ET | DEF 14A | Proxy statementPeriod 2024-08-02 | 0001493152-24-030135 |
| 2024-08-0121:07 ET | 8-K | 3.01 Delisting notice | 0001493152-24-029939 |
| 2024-07-1621:26 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-028050 |
| 2024-07-1220:12 ET | 8-K | 5.07 Shareholder vote results | 0001493152-24-027090 |
| 2024-06-2820:15 ET | DEF 14A | Proxy statementPeriod 2024-06-28 | 0001493152-24-025614 |
| 2024-06-2823:55 ET | 10-K/A | Annual report, amendedPeriod 2024-03-31 | 0001493152-24-025493 |
| 2024-06-2701:58 ET | 10-K | Annual reportPeriod 2024-03-31 | 0001493152-24-025344 |
| 2024-06-2413:25 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-024888 |
| 2024-06-0720:34 ET | 8-K | 3.02 Unregistered sale of equity | 0001493152-24-023126 |
| 2024-05-2811:31 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-021454 |
| 2024-05-2121:00 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-020909 |
| 2024-05-0320:59 ET | 8-K | 3.01 Delisting notice; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-017744 |
| 2024-04-2321:16 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-015713 |
| 2024-04-0310:07 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-012898 |
| 2024-03-2621:18 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-011344 |
| 2024-02-2801:45 ET | S-1 | Registration statement | 0001493152-24-008031 |
| 2024-02-2022:02 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0001493152-24-007244 |
| 2024-02-0222:30 ET | 8-K | 3.01 Delisting notice | 0001493152-24-004806 |
| 2023-11-1421:57 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-041243 |
| 2023-11-0621:55 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-039557 |
| 2023-09-2012:15 ET | 8-K | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-23-033139 |
| 2023-08-1712:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-029242 |
| 2023-08-1420:26 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001493152-23-028510 |
| 2023-08-0420:15 ET | 8-K | 3.01 Delisting notice | 0001493152-23-026879 |
| 2023-07-2021:14 ET | 8-K | 8.01 Other events | 0001493152-23-025121 |
| 2023-07-0520:05 ET | 8-K | 2.02 Results of operations; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-023428 |
| 2023-06-2921:29 ET | 10-K | Annual reportPeriod 2023-03-31 | 0001493152-23-022974 |
| 2023-05-1820:41 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-018125 |
| 2023-04-0321:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-23-010668 |
| 2023-03-1320:21 ET | DEF 14A | Proxy statementPeriod 2023-03-13 | 0001493152-23-007414 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.